[Concluding report of a 3-year clinical study on cyclamate].
D001798:Blood Proteins / Q000032:analysis; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D003494:Cyclamates / Q000009:adverse effects*; D005260:Female; D005500:Follow-Up Studies; D005632:Fructose; D006801:Humans; D007674:Kidney Diseases / Q000503:physiopathology*; D008107:Liver Diseases / Q000503:physiopathology*; D008297:Male; D010919:Placebos
D001798:Blood Proteins; D003494:Cyclamates; D010919:Placebos; D005632:Fructose; D002784:Cholesterol
Abschlussbericht einer dreijährigen klinischen Prüfung von Cyclamat.